target,target_id,target_uniprot,target_species,ligand,ligand_id,ligand_species,ligand_pubchem_cid,smiles,inchi,inchikey,type,action,action_comment,endogenous,primary_target,concentration_range,affinity_parameter,affinity_high,affinity_median,affinity_low,original_affinity_units,original_affinity_low_nm,original_affinity_median_nm,original_affinity_high_nm,original_affinity_relation,assay_description,receptor_site,ligand_context,pubmed_id
"c-ros oncogene 1, receptor tyrosine kinase",1840,P08922,Human,lorlatinib,7476,,71731823,N#Cc1n(C)nc2c1c1cnc(c(c1)O[C@H](C)c1c(C(=O)N(C2)C)ccc(c1)F)N,"InChI=1S/C21H19FN6O2/c1-11-15-7-13(22)4-5-14(15)21(29)27(2)10-16-19(17(8-23)28(3)26-16)12-6-18(30-11)20(24)25-9-12/h4-7,9,11H,10H2,1-3H3,(H2,24,25)/t11-/m1/s1",IIXWYSCJSQVBQM-LLVKDONJSA-N,Inhibitor,Inhibition,,,yes,,pKi,,11.3,,Ki,,0.005,,=,,,,,
"c-ros oncogene 1, receptor tyrosine kinase",1840,P08922,Human,compound 8e [PMID: 24432909],8137,,72710568,OC[C@](c1nc(c(s1)c1cnc(c(c1)O[C@@H](c1cc(F)ccc1n1nccn1)C)N)C)(O)C,"InChI=1S/C22H23FN6O3S/c1-12-19(33-21(28-12)22(3,31)11-30)14-8-18(20(24)25-10-14)32-13(2)16-9-15(23)4-5-17(16)29-26-6-7-27-29/h4-10,13,30-31H,11H2,1-3H3,(H2,24,25)/t13-,22-/m1/s1",DIXMBHMNEHPFCX-MCMMXHMISA-N,Inhibitor,Inhibition,,,,,pKi,,10.7,,Ki,,0.02,,=,Value calculated from tight-binding (Morrison) equation for competitive inhibitors tested in a Pfizer mobility shift assay.,,,24432909,
"c-ros oncogene 1, receptor tyrosine kinase",1840,P08922,Human,gilteritinib,8708,,49803313,COc1cc(ccc1N1CCC(CC1)N1CCN(CC1)C)Nc1nc(NC2CCOCC2)c(nc1C(=O)N)CC,"InChI=1S/C29H44N8O3/c1-4-23-28(31-20-9-17-40-18-10-20)34-29(26(33-23)27(30)38)32-21-5-6-24(25(19-21)39-3)37-11-7-22(8-12-37)36-15-13-35(2)14-16-36/h5-6,19-20,22H,4,7-18H2,1-3H3,(H2,30,38)(H2,31,32,34)",GYQYAJJFPNQOOW-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,8.82,,IC50,,1.5,,~,,,,27908881,
"c-ros oncogene 1, receptor tyrosine kinase",1840,P08922,Human,repotrectinib,10316,,135565923,C[C@H]1CNC(=O)c2cnn3c2nc(N[C@@H](c2c(O1)ccc(c2)F)C)cc3,"InChI=1S/C18H18FN5O2/c1-10-8-20-18(25)14-9-21-24-6-5-16(23-17(14)24)22-11(2)13-7-12(19)3-4-15(13)26-10/h3-7,9-11H,8H2,1-2H3,(H,20,25)(H,22,23)/t10-,11+/m0/s1",FIKPXCOQUIZNHB-WDEREUQCSA-N,Inhibitor,Inhibition,"IC<sub>50</sub> for ROS1<sup>G2032R</sup> is 0.5 nM, and for ROS1<sup>D2033N</sup> is 0.2 nM",,,,pIC50,,10.15,,IC50,,0.07,,=,,,,30093503,
"c-ros oncogene 1, receptor tyrosine kinase",1840,P08922,Human,taletrectinib,11198,,72202474,CC(COc1ccc(cc1)c1cnc2n1nc(cc2)NC(c1cccc(c1)F)C)N,"InChI=1S/C23H24FN5O/c1-15(25)14-30-20-8-6-17(7-9-20)21-13-26-23-11-10-22(28-29(21)23)27-16(2)18-4-3-5-19(24)12-18/h3-13,15-16H,14,25H2,1-2H3,(H,27,28)",HEVHTYMYEMEBPX-UHFFFAOYSA-N,Inhibitor,Inhibition,,,,,pIC50,,9.7,,IC50,,0.2,,=,,,,31399568,
